Lonnel Coats is Chief Executive Officer of Lexicon Pharmaceuticals Inc.
Person profile
Roles
Lexicon Pharmaceuticals
Chief Executive Officer
Verve Therapeutics
Director
Blueprint Medicines
Director
Address
the Woodlands, Texas
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
LEXICON PHARMACEUTICALS, INC.
1 Mar 23
4
LEXICON PHARMACEUTICALS, INC.
13 Feb 23
3
Verve Therapeutics, Inc.
9 Aug 22
4
Verve Therapeutics, Inc.
9 Aug 22
4
Blueprint Medicines Corp
30 Jun 22
4
LEXICON PHARMACEUTICALS, INC.
28 Feb 22
4
LEXICON PHARMACEUTICALS, INC.
14 Feb 22
4
Blueprint Medicines Corp
4 Jun 21
4
LEXICON PHARMACEUTICALS, INC.
2 Mar 21
4
LEXICON PHARMACEUTICALS, INC.
16 Feb 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Feb 23 | LXRX Lexicon Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 2.17 | 50,971 | 110.61 k | 744,359 |
28 Feb 23 | LXRX Lexicon Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 91,363 | 0.00 | 795,330 |
28 Feb 23 | LXRX Lexicon Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 33,334 | 0.00 | 703,967 |
28 Feb 23 | LXRX Lexicon Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 84,630 | 0.00 | 670,633 |
28 Feb 23 | LXRX Lexicon Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 91,363 | 0.00 | 182,727 |
28 Feb 23 | LXRX Lexicon Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 33,334 | 0.00 | 33,333 |
28 Feb 23 | LXRX Lexicon Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 84,630 | 0.00 | 0 |
9 Feb 23 | LXRX Lexicon Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 2.43 | 1,083,440 | 2.63 mm | 1,083,440 |
9 Feb 23 | LXRX Lexicon Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 361,150 | 0.00 | 361,150 |
8 Aug 22 | VERV Verve Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 27.17 | 31,000 | 842.27 k | 31,000 |